Bakley Pharmaceuticals Private Limited
About Bakley Pharmaceuticals Private Limited
Data last updated:
Bakley Pharmaceuticals Private Limited is a private limited company based in Kichha, Uttarakhand, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 17 May 2023.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U21002UT2023PTC015652.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Neelu Gulati and Shilpi Chaudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kichha, Uttarakhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.25 Lakh, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹22,000 (net margin 0.9%) and EBITDA of ₹67,000 (EBITDA margin 2.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Mr. Girish Babu Shop, No.5/1 Prabal City, Kichha, Uttarakhand, India – 263153
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bakley Pharmaceuticals Private Limited
The main business activity of Bakley Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bakley Pharmaceuticals Private Limited FY 2025 filings available
Bakley Pharmaceuticals Private Limited reported revenue of ₹23.25 Lakh (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bakley Pharmaceuticals Private Limited
Revenue rose 131% in the latest year. EBITDA rose 203% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Bakley Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹67,000 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹22,000 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Bakley Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.9% | •••• |
| Net Profit Margin | 0.9% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bakley Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bakley Pharmaceuticals Private Limited
Bakley Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Capital Pharmaceuticals Private Limited | ₹23.42 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Nani Daman, Daman and Diu, India |
| Glydous Pharmaceuticals Private Limited | ₹23.42 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Rantas Pharmaceuticals Private Limited | ₹23.39 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Solan, Himachal Pradesh, India |
| Uencure Pharmaceuticals Private Limited | ₹23.34 Lakh (FY 2021) | •••• | •••• | 104.0% | •••• | Po Kala Amb, Tehsil Nahan, Himachal Pradesh, India |
| Enola Pharmaceuticals Private Limited | ₹23.31 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Bakley Pharmaceuticals Private Limited this company | ₹23.25 Lakh (FY 2025) | •••• | •••• | 131.0% | •••• | Kichha, Uttarakhand, India |
| Terveysliv Pharmaceuticals Private Limited | ₹23.2 Lakh (FY 2025) | •••• | •••• | •••• | Surat, Gujarat, India | |
| Philbert Pharmaceuticals Private Limited | ₹23.16 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Surat, Gujarat, India |
| Grassindia Pharmaceuticals Private Limited | ₹23.14 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Aurangabad, Maharashtra, India |
| Revive Pharmaceuticals Private Limited | ₹23.11 Lakh (FY 2025) | •••• | •••• | 81.0% | •••• | Mumbai, Maharashtra, India |
| Airmed Pharmaceuticals (India) Private Limited | ₹23.09 Lakh (FY 2020) | •••• | •••• | -47.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Bakley Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bakley Pharmaceuticals Private Limited
Bakley Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelu Gulati | Director | 17 May 2023 | 3 Years 4 Months | Current |
| Shilpi Chaudhary | Director | 17 May 2023 | 3 Years 4 Months | Current |
| Nirmala Gupta | Director | 28 Jan 2026 | 0 Years 8 Months | Current |
Charges & Borrowings of Bakley Pharmaceuticals Private Limited
Bakley Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bakley Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Bakley Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bakley Pharmaceuticals Private Limited
Bakley Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Nirmala Gupta was appointed as Director on 28 Jan 2026.
Credit Ratings, Litigation & Regulatory Alerts for Bakley Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bakley Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bakley Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bakley Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bakley Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bakley Pharmaceuticals Private Limited
Bakley Pharmaceuticals is an active private limited company based in Kichha, Uttarakhand, India. The company works in paper and paper products, within the paper industry. It was incorporated on 17 May 2023 (3+ years old) and is registered under CIN U21002UT2023PTC015652.
Bakley Pharmaceuticals reported revenue of ₹23.25 Lakh for FY 2025 (up 131% YoY).
Bakley Pharmaceuticals has 3 current directors:
- Neelu Gulati - Director
- Shilpi Chaudhary - Director
- Nirmala Gupta - Director
Bakley Pharmaceuticals reported a net profit of ₹22,000 (net margin 0.9%) and EBITDA of ₹67,000 (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Bakley Pharmaceuticals is U21002UT2023PTC015652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bakley Pharmaceuticals was incorporated on 17 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Bakley Pharmaceuticals by revenue are Capital Pharmaceuticals Private Limited, Glydous Pharmaceuticals Private Limited, Rantas Pharmaceuticals Private Limited, Uencure Pharmaceuticals Private Limited, Enola Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Nirmala Gupta was appointed as Director on 28 Jan 2026. Krishna Pal ceased to be Additional Director on 20 May 2024. Neelu Gulati was appointed as Director on 17 May 2023. Bakley Pharmaceuticals has 4 board changes on record in total.
The registered office of Bakley Pharmaceuticals is at CO Mr. Girish Babu Shop, No.51 Prabal City, Kichha, Uttarakhand, India – 263153.
Bakley Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh.
Bakley Pharmaceuticals operates in the paper industry, in the paper and paper products segment.